US 12181485
Methods of blood screening
granted A61KA61K2039/505A61P
Quick answer
US patent 12181485 (Methods of blood screening) held by CASI Pharmaceuticals, Inc expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CASI Pharmaceuticals, Inc
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00